| HOME >> BIOLOGY >> TECHNOLOGY |
Ms. Rector continued, "We have now established our US Sales and Marketing Organization and we are excited about starting sales in the US Market. Based on the initial market reaction, there is clearly a great, untapped need for Cheetah's unique and proprietary technology."
About the BIOREACTANCE(TM) Technology
The Cheetah family of NICOM Cardiac Output Monitors implements the unique and proprietary BIOREACTANCE(TM) technology. BIOREACTANCE is a novel technology platform which analyzes changes in amplitude as well as frequency of electrical impulses as they traverse the chest. These changes are analyzed by software programming to provide a continuous, highly accurate and stable, non-invasive measurement of cardiac output and other cardiac parameters.
About the Company
Cheetah Medical is based in Tel Aviv, Israel and Indianapolis, Indiana.
The company is establishing NICOM(TM) as a frontline tool to monitor
cardiac function in inpatient and outpatient areas of high unmet need.
Importantly, this unique and proprietary technology has been proven to
provide accurate and reliable measurements of cardiac output, even during
patient movement and across a variety of body types. These features enable
the device to be used in several important clinical applications, including
intensive care, anesthesia and peri-operative settings, step down,
emergency room, dialysis clinic, cardiac care unit, ECO(TM) (Exercise CO
testing), CRT-pacemaker optimization, thoracic fluid content (T
'/>"/>
| SOURCE Cheetah Medical Inc. Copyright©2007 PR Newswire. All rights reserved |